Compare UGRO & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UGRO | NOTV |
|---|---|---|
| Founded | 2014 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 10.8M |
| IPO Year | 2018 | 1997 |
| Metric | UGRO | NOTV |
|---|---|---|
| Price | $2.99 | $0.16 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 72.1K | ★ 2.3M |
| Earning Date | 04-15-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 49.64 |
| EPS | N/A | ★ N/A |
| Revenue | $17,399,438.00 | ★ $547,656,000.00 |
| Revenue This Year | $462.72 | $5.28 |
| Revenue Next Year | $86.37 | $5.42 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 511.19 |
| 52 Week Low | $0.11 | $0.08 |
| 52 Week High | $39.68 | $3.19 |
| Indicator | UGRO | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 30.66 | 40.75 |
| Support Level | $2.13 | N/A |
| Resistance Level | $3.41 | $0.34 |
| Average True Range (ATR) | 0.41 | 0.04 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 6.03 | 41.68 |
Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.